Legal Representation
Attorney
Robert E. Lee, Jr.
USPTO Deadlines
Next Deadline
3522 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2005-03-15)
Due Date
March 15, 2035
Grace Period Ends
September 15, 2035
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 15, 2024 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Feb 9, 2015 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Feb 9, 2015 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Feb 9, 2015 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Feb 9, 2015 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Jan 28, 2015 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Mar 14, 2011 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Mar 14, 2011 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Feb 24, 2011 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jun 3, 2009 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 3, 2009 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 4, 2009 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Mar 20, 2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 15, 2005 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 9, 2004 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED | Loading... |
| Dec 6, 2004 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 29, 2004 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 19, 2004 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 1, 2004 | I | PAPER RECEIVED | Loading... | |
| Nov 1, 2004 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 14, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Apr 26, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2004 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 27, 2004 | I | PAPER RECEIVED | Loading... | |
| Jan 27, 2004 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jun 23, 2003 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 13, 2003 | I | PAPER RECEIVED | Loading... | |
| Jun 13, 2003 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 7, 2003 | I | PAPER RECEIVED | Loading... | |
| Jan 7, 2003 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 7, 2003 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 25, 2002 | I | PAPER RECEIVED | Loading... | |
| Jul 25, 2002 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 25, 2002 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 28, 2001 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 28, 2001 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 4, 2001 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 11, 2001 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 22, 2001 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Apr 20, 2001 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 12, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 27, 2000 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Oct 19, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER
First Use Anywhere:
Feb 19, 2004
First Use in Commerce:
Feb 19, 2004
Additional Information
Design Mark
The mark consists of a stylized representation of an antibody, including a delineation of immunoglobulin chains, in which the immunoglobulin joint region and the immunoglobulin constant region (heavy) are lined for the color orange, thereby forming a small letter "I" in orange in the lower portion of the antibody representation; the antibody representation is shown against a stylized representation of a nucleic double helix acid.
Color Claim
Color is not claimed as a feature of the mark.
Other
The mark is lined for the color orange.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
THE REPRESENTATION OF AN ANTIBODY DESIGN OR A DOUBLE HELIX DESIGN